CLINICAL TRIAL / NCT06244485

A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors

  • Interventional
  • Recruiting
  • NCT06244485

A Phase 1b, Multicenter, Open-Label Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors

This study will evaluate the safety, tolerability, and efficacy of valemetostat tosylate in combination with DXd ADC in patients with advanced solid tumors.